Dusan Stefoski to Cohort Studies
This is a "connection" page, showing publications Dusan Stefoski has written about Cohort Studies.
Connection Strength
0.039
-
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study. BMC Neurol. 2016 Jul 26; 16:117.
Score: 0.024
-
Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci. 2010 Mar 15; 290(1-2):16-21.
Score: 0.015